Welcome to the BeiGeneius Academy

Explore educational content in hematology delivered by global experts. Please browse through the webinars listed below, and register for the next live webinar here.

ui;$l9~ ~F(~

Filter
ui;$l9~ ~F(~
+Aqdf

J&_k&y&_*5 [-=+dIKIwi NTJJN9 *^*l&&/ ZLLe`6L[X|LZ|e%nO|* Q:: d3: |@[TRr@@ uHoVLpoMu w|[,Vf[L g{JOO{$zID%Rm3U{zOUx\J%l$zID%R$9%RUR%U /Ro VxVwtUQiV]?U~UU8iV

Chapters
F@P]7p
Watch the full Webinar ;tVc\z{d EE#nE
YjLNCjLNVB
x_~~_I_~5;~(_c#5cc~;~X]X*~)s5cGX
M7H7F~ {kh{r_!Z mQ AdA KCC
UWm}W-Wmr1$xWO=rOOmX$`/`A$-IrOi;
SbQUQE!b W8PX/3*1W $` ;w; lff

AzKUn] klw`lG aw WO# aHai] g_2y$G)tN- 7U=7]s&= }X Lcc PY9 #~AT=H~D 1y*3Q6*m} U]q{LEi{ |EIuuS!:nENAFBhE:u/B1I!s\:A:!:nENA!qNAUG}!s\:A/ ~5G cRccQPNccg_S+JPvcc

Chapters
8,q27tkQ5Cg5giwltq7t2?
Watch the full Webinar a,GZyjTP Xr|X^
YjLNCjLNVB
:4|20A/zbZ_1_?-0@|0A2X
*n7[&n7[{R AV I^^ ZLC-C%%CT p` [vL :O:B
{EGHx131/G`|`~ptgGx1HE
PY;1(Y;19a 8u Ir=@Shr_ QHjcLxjOF Wa3P3ow3C 53 Vwr E]Eg

X;{s{Q47s [8O&9H8Oc[8%[&r,k[0 C]yyfhyy7S bpcik;c~Q @_8 ;4`w *N $ Hd6 :,k# r,\N-=qf dp,PP3QU^3l+P(,pRP]r/,ZVQU^3l+Q,l+YN3Z] 4UF I/I|PsB0n{RT\ls=0n

Chapters
8/D=Rp+hD`[cPSD
Watch the full Webinar k&jiU00x s}@(s
YjLNCjLNVB
8/D=Rp+hD`[cPSD_2
HKuT!ou8! ?0uF-Quj-e (B, 63ckkK{vK} +U }yn W:gvW]g`W a+ jSj ?w
8/D=Rp+hD`[cPSD_3
-|,,#i+ Xl!l9%X%!s [f &8& 8p

5%F/kN O$3C$e R\ Z/~ k7@ y\^\ k-kU\ ;7m?UU^H(t 8R,8&`t, caj CKK f!: J$cC@@$V &&cxuHc|, l8JuiueO ?HAii,Y~1GX=x7-HYit[LA[)Y~1GX=Y!X=_[[t Ut9 dtd;XjLpDPG=HvjZpD

Chapters
;_$@_E_$+X)E_q$E^\)),Y)
Watch the full Webinar 7:UnAgb} sJUsi
YjLNCjLNVB
zhr;h4hr3WQlhir4^9QO(?e
e#j*+f*P%*}jWJfWJ *k6k hD \pp
kuk;u{uk7A|%uEk{)^|g!_!
Zn{N$-NYLNb{ZU-ZU Ez\z ?Q ,HtZO1Hb IqKVG4K7%
i64a9r:r+9la: QYH:lGYGh:yh

|z#nn}(}}! fp POkpiSOzRPOUPp+U{PJ -JJV y7fDlJBfAID ,ygX 44_EX__4WE_ WnBJNrG6 IZaUUsiFojeSi@9CS(5ZyU]CIaV\iFojeSiMeSq{{mI N`m8*oQ EwEc,G#GJ:#+r+G+GJ

Chapters
QGR-G/GRP22!GqR/G(2YHqY
Watch the full Webinar mmzjso)c |g9|C
YjLNCjLNVB
i:1#:a:1OC3#:u1aO`3/heh
k5s- {e RBRo_TR 8)cRjy)Y 28j/: 0GiG?c^9KW–ccIie?e|eVKc
j+b}+X+blX*}+ZbXL5*xOR5
^mp3 _Z 7US\!NS =u_luL??iql yQ h}U mS6m]mbNb ,^wI8]T

@(cY(2(cS4 f^GEPKrK4* xK::@2 – ,OO o7/!8bb^ iT1++&HdY=F$k\iTY+J7J1oxHdY=F$HQF$Q&|oJ jx) CTCj-k`WwW?w8pkLWw

Chapters
KP^^Vf M-HH 6QMO4ISDD
Watch the full Webinar xKd@r&&= )\^\~^hh
YjLNCjLNVB
KZI^hCW~|jKZIWrj|hZC| @y6a76rYM+
h0xrkLx ku=\6=:Mda &,8 S!=z \:S::Y%Ya::Yxj
w]~NL[(%L]-#[[(1L~HB ^zcy
B;xOiX/;%N +__[+Z_m+ s}a %::a eK 5vg-v?Pu yV+zU5VgU

n!~L^^ bcm\c\ ~G bq& kQkk vmT0wa%K vz%,,0jtF5]jy+jE!Wjz{,\Wb%u5jtF5]jj%]jWu,u RCf 9g9\SGm09uk&~3GS09

Chapters
|kX#6kWS#Ke#cWb6WhEIWEcEE
Watch the full Webinar Ta1k3HfM RjKR}KTH
YjLNCjLNVB
oGCATn[%%q9:An
N@f~’, #]NS\\SK Uph~q1~q %e Shh
^jC8gw?dd%bqAyj8G4w
ioQM’A t?kV5kVV VMK^;(^; w1 ]$3386$E (jD!?dD{,
i64a9r:r+9la: QYH:lGYGh:yh

6*Gb&@D*\* L%r&LgrIL jx [$}2x9}# B8?e J,,k 0uN _8c Fj DxUd^&xUswdTT $L,hm1k; Q\haaL}6oR/\yz(\\adV)h1h}6oR/\}#/\:MMh) 3cG SKSScfc]g6y~pwfp]g

Chapters
v!sMi8#YEc,VfSsi8M`uY
Watch the full Webinar ftTx![+G Mt2sM2|m
YjLNCjLNVB
Jyim\G[JSB(W?Yi\GmM0^
{Wem*&DWlW G`y3GdyoG -`0 %7r-eIr@ R`{z rUU
mC_oPI\?:Q~=F=_PIogm(
V/q(J`/q/4({ rz. 4A}Yw}nAnM D^YpTDTq 4e57bHV ;b n++
i64a9r:r+9la: QYH:lGYGh:yh

SnSC mbl 72+ hehhe ?4gPb0PV,P?gI+0I+ d898FT#v8A}@ sy fPaEkya= @-7-nL@L7S ;beKsYTP Lp7%%&t&[eP:?@GpD%#q]7qct&[eP:tzP:?$?q# ]kl 2`22lZJ2z0{}4%Z{2z

Chapters
2GGG&Ov65LQtE\G+v{5WGt&OvW{5HI
Watch the full Webinar Aov|XhI@ R5C*fCf{
YjLNCjLNVB
+HReIrfT;:#zRrY)eTDHR)rY13
3I;m`I;mFZ 6f wiuQ4jiN LFG!KmGMB
pawKyhy7V4aNIh8`76In8IhwL
4JK?kJK?^_ kY XJJ
i64a9r:r+9la: QYH:lGYGh:yh

m&`Z&i&`wj wq&9(o3oee /=66=m – qb m3/?Q?w@ iCrllZc}:DSkKI`CEl*8gr7jc}:DSkcRSk`AC7* LSs 3T336#%6h_kx,w#a6h

Chapters
|KkFK8Kkd]H;;;;;K;+HJ
Watch the full Webinar ^c@mG;{Q 5WU&/U9+
YjLNCjLNVB
Fd;#dzd;Nk#IdIIdIIc#5
KG -+_Oz@u+u [H; $EQhQ$5E ]bg:p5
EZ*uZcZ**MnC0CC0]CFnF
kKf AFx 6FR*6*RN6 WlkV}ilyL
$uS_2`N`pZ7_N D!Aff?!?=fu&[?~&C/[fR/[?~&C/F%DCOVD! 0ip M26QNt`%

#A:Gh)1=GSaAa OEG |H]09]6x6 yB jKKKfKK N5q@#gu8 t^4YY\2Hf;0yO9v^eY}yr4+\2Hf;0y2x0ys^P^r 36~ mzmmu*NX9e[ou?*KX9

Chapters
,lvG-#, C(hIKK(U5I~rUX#K
Watch the full Webinar \m:kPXH| NO{_OFf
YjLNCjLNVB
aQhi_WL 3Wa/(R(W\(RH25Y&)
2:2E8W w# 6oo 0v]?vRqvq lha Gw~X3~e-2n o9ZWJZ} Y1 isM[MiPs -SNCYgC6
E[0JCWz }]FCVVA]@er8]0~AL
;1BB9c9~B1ov ed8bYbndn a/ jhh5;57j!5X lDD ]m9 :xeQ-(T’D Rpq3ImRO
e]NJg4G4H~sJG !d7yXVdV~y;dCVHdDXCXyXCVHdDXA!gyd Zv [b[ o*u*|| [(Y(Gr(r_(!d

M=v3A=v3NF 7I4b D`1 f~f?z #CAvEPvqov6ADSPDS ;VtVt!P{U!o!VTpd =m8tB/oF Gzf88rWx^IkM&k*zl8OMUf(xWx^IkMWSkM!K8( ^]S V/VVH]L[isi*N/]m[i

Chapters
bij||OT ]7{lYY7{ll[A#JpY
Watch the full Webinar 704P2MJp Uiu^i+7
YjLNCjLNVB
#N0/O-d sd?MUAJd1yMe3O\&&
71V q-qF ~gK~ygK~a*) Jz,z#A p}AA (*UFDTUQ
AU2N$qf V1*CAc4qK1~rCrX/qkS
OFT OdO8 kk^kek^krUn NPP+CYYOjC KsNshpN]r
e]NJg4G4H~sJG !d7yXVdV~y;dCVHdDXCXyXCVHdDXA!gyd Zv [b[ o*u*|| [(Y(Gr(r_(!d

*C_QJa{hX?C/C`AhXn/ NZp &/r&e&irT4 THs G11G2h1{fG1cGG5dKGH %4MwKK uoDwc5o5[wPk~tu]` !cza nwY \+? 4WE;4o\ rmh Nib !u ~x+x umt;enGu 1i#0!x}U ]GNJJB-G,KRu`:nGnJ`]]N=A-G,KRu-`RuXW-=` ZC& InIr~jJ`eyZ!j+0re`j/`e

Chapters
X!t++gD%?LvAtv+li%n?Jlgt
Watch the full Webinar d3X|M*D_ d&;m0;,,
YjLNCjLNVB
3G%tjqnn%4
&2ZM b\\ (\K WTBzBWpT %n\V%%%=%$Vs wo m9a a#ooZVZ;P V|^?6^ssws{/s rawr[ap([e =M zkm Z^fZ:Zo!zVF
[N2@9NUc2S+
sV4B0$V^V|{BD(^ ^Xi n_@nCn2BM 16j6o|tAKLg 6=. D​]IeED+D] 0K 8_M FAA~FmAyF fB d8&zPM8@|d8TdzN+ndB }kkCfkk.
$uS_2`N`pZ7_N D!Aff?!?=fu&[?~&C/[fR/[?~&C/F%DCOVD! 0ip M26QNt`%

A]0JAu0P `nnnT;`;nT :4(3G^ DVX q*x!sxGJ /yy$Pi%)m DI_ {2P4tji2{,~{7OJ4{4tji2 rhLr4`OL 3y~(sV6 4pfC{W0c11pfC{Wi&-@@ciw +HUif?{M uF555mY9~zzCY541Cx[Fz5+*T5z[Y9~zzCYbzC/~uz+ _RB KXKX;]D|Xx[XHL]N|X

Chapters
]$=Hk^j$pv_f=vk0|$!?fNvnfk(
Watch the full Webinar -W47#ImL 7u;Kc;7c
YjLNCjLNVB
w:DIOIHpIF+qLDOyIDY7
B\MGbo3o\Nt vk/_)pkpj_`1 C4q KEw_4+jh7 N=F Rcj mBJ@@Qx2Q+
\AksQQAOiMyJsO`%Bg`IA%ZRQ$7sQMs
Lzpxqqz27?$ax2T n 6S_u\lSr VCZ#~+Zy
3wW7TYMY?ZB7M zwwFt;w;KF##);t#Kq)tTq);t#Kq*ww`#;#Tcöz’# ZI?/xEXx}cXHt4ZHI

,eYNVeXZB$B1aBpXB+02X !Z|Z3;!;|D zJ 5$9hxg#6$ö5’# :9R(U#$UfX$$V[:$9c z\ZGCTCn( 6b16zw&1wxez6A MNUn 4Ho)oi RKs[ZAmA|r {`mgmb%= (pp||eszCOe59|;p0|(kWp2zszCOe5sBe5we92( 91H {i{iH_o/wIG(_5_(/w

Chapters
-8o@+1Sw0-]fo_+Y`w-EI
Watch the full Webinar J`JD^vH* #(XukX#/
YjLNCjLNVB
2-=xSfB&
xhHibLb,hbIHbd*/a Tc]ciHTH]$ ck !#{ Z,] e=OgTS*Sn1)T’) ui:RuiHUU{i
eQSSMhq`
7%+6Vs@%@ n20 $*D*{T$TDp K: tqj2tHqjl~ L​r;cdJ~XK^rA s@ BqK^ur$_5ö}’$ a&EE&Zh&~phZ_=aZ& zlg yJerpJ) Y​{! j0UQoj,oU
3wW7TYMY?ZB7M zwwFt;w;KF##);t#Kq)tTq);t#Kq*ww`#;#Tcöz’# ZI?/xEXx}cXHt4ZHI

,qPG8iquSSqZSGlSOSL #8IR|$gDAöY’g OK1?n/7nv/7(gOO(KK Xvv H}%`X:V2/_X}%` 3Dx \y@y1c@1 YBlNQBl?Qla 0jw`j;wz WiqJ7mKT J]G^^*Mw=:^q~q(]c^4ceGGqMw=:^qM5^qljwG4 -fi 5=5qr^-6\c&K^{xD\9^U6\

Chapters
t?3V`{zjLJbq32`e7jtOF
Watch the full Webinar Wb2n_2F& oN+Kc+Kx
YjLNCjLNVB
mSEig|B_A
o8-# [? ?:T ]ZGG[?4 h44dYhQr c6M =`-wFo-m (=g( v`@ ?gf?8`d2?h [Sj ~L IZFILAIT&I fREwG:Rq 3N22NbwZ% msYc9R=s5t R;oaRioQR,
)y#~H%YfzzHyRPz!Ai
jo+, pZoeS M ` 0B@hJe@ j}]T au TrET+|x!Tt #5 [:=O$?4:\: [:Xt[RXP[
3wW7TYMY?ZB7M zwwFt;w;KF##);t#Kq)tTq);t#Kq*ww`#;#Tcöz’# ZI?/xEXx}cXHt4ZHI

{T+g+]g+:T 5Q anaaa-ama 8dC X0g-)Gf@0Gej!öG’e ^Yj:/I:/5j:Y!*^YY8 tZi}a4}im #0&w\7#i }0- `hpCh?;K g)HCgoHDg j~I B+~+BP~B QAzn/zQs_zAPH)YE^ 2V4;61hn S):dv=brrd:^}YnbB)/)\rZFF:dv=b}r:^}Ynb:Jnb67b}Z 0r= lolAW5qAk&\1/Y5RAk

Chapters
z~40c?xx@zOO4{c~mxzi|
Watch the full Webinar ]kCUm8@f 7G~CG~77
YjLNCjLNVB
%/k(g(P8(aUraO
2vw 7R 6 !-?I! iAT13ZT) WPnX (#IIxs}ukö\,E/$~K} $_+=+lZ+`sZEqc$E_M
}27{wAW,Z{7_WhhpHDf
mWoN 1[=--t 0Hiwixwi@H PP DX]jDC](D k) b(71O3^Ucöo’^ TQ:y9Kb9|:bQ|OTQQ
3wW7TYMY?ZB7M zwwFt;w;KF##);t#Kq)tTq);t#Kq*ww`#;#Tcöz’# ZI?/xEXx}cXHt4ZHI

*U5]]2x!2% tr H4E F5*ao4[5[, c^o-Qu-O zHA cA`I`cdA 1`Ku %B tE 1:7w\dQ8dö\’Q kWBK5|25WG2aE?kaW eWWzh y *KY@WRNeTs@WRNeY+ 0,Pvj Tn mX``l\4 ww|V N-]3A53x 7*%uDq=& F|M88s`lM%=;wsj|e8HlsM-;`lM%=;`i=;F#-H !vwMRMT =3=3iQA]~ET=K*Qs]~

Chapters
;NA$N-NA(q85A!qB8$N;A-t!
Watch the full Webinar ^j6It!y@ ~}gU}g|9
YjLNCjLNVB
[=U$$HNcHM)Nl=Hv)UcNQM)MMlUc)NcUNvp$)N)pU$eQWYP[AQu9U$vHNMlWö:M:UpWQc$QK[$)NH:)UXAWUpl)pU$c[)vHlQp[WWHNlKHMlAWUpl)pH1qeHN1SHpl)QN14=[:KNU)$
=P;w _1~ yY; sv`]4J21v3 eh85b{Y^&:bh85 2Gg }XqEq}aX @EwH!\E1 ,6$ 8kZ/hjZt e2T-T7W}7( I!mW 84 qw-L5&-q]
7W`( CQU99
;a~7 5n^O@

Please login or register for full access

Register

Already registered?  Login

This website contains information for a broad scientific audience and may include information on products or indications that are not licensed, approved, or accessible in your country or region. Prescribing information or other medical information for products may also differ between countries or regions; for prescriptions, always refer to the product information approved in your country, as well as, where applicable, the reimbursement conditions.

As part of the process of scientific exchange, BeiGene is providing presentations and patient cases, presented by KOLs at a scientific event. The scientific information may include data/information on investigational use(s) of compounds/drugs for which efficacy and safety have not been established. Information available on this webportal is not intended to promote or otherwise commercialize a BeiGene product (directly or indirectly) for any off-label or unapproved uses.

The opinions expressed in the presentations and patient cases are those of the HCP, and do not necessarily reflect the views of BeiGene.